David H. Kirske
2019
In 2019, David H. Kirske earned a total compensation of $831.9K as Executive Vice President, Chief Financial Officer at CTI BioPharma, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $158,620 |
|---|---|
| Option Awards | $305,800 |
| Salary | $359,073 |
| Other | $8,400 |
| Total | $831,893 |
Kirske received $359.1K in salary, accounting for 43% of the total pay in 2019.
Kirske also received $158.6K in non-equity incentive plan, $305.8K in option awards and $8.4K in other compensation.
Rankings
In 2019, David H. Kirske's compensation ranked 10,055th out of 13,971 executives tracked by ExecPay. In other words, Kirske earned more than 28.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,055 out of 13,971 | 28th |
Division Manufacturing | 4,062 out of 5,695 | 29th |
Major group Chemicals And Allied Products | 1,543 out of 2,194 | 30th |
Industry group Drugs | 1,321 out of 1,880 | 30th |
Industry Pharmaceutical Preparations | 983 out of 1,392 | 29th |
Source: SEC filing on April 23, 2020.
Kirske's colleagues
We found two more compensation records of executives who worked with David H. Kirske at CTI BioPharma in 2019.